Shares of PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) fell 2.4% during trading on Thursday . The company traded as low as $1.65 and last traded at $1.65. 89,036 shares were traded during mid-day trading, an increase of 88% from the average session volume of 47,379 shares. The stock had previously closed at $1.69.
PureTech Health Stock Performance
The stock’s 50 day moving average price is $1.65 and its 200-day moving average price is $1.68.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
See Also
- Five stocks we like better than PureTech Health
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
